Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)

ClinicalTrials.gov ID: NCT02781584

Public ClinicalTrials.gov record NCT02781584. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)

Study identification

NCT ID
NCT02781584
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
220 participants

Conditions and interventions

Interventions

  • SEL Drug
  • FIR Drug
  • CILO Drug
  • FENO Drug
  • VAS Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 12, 2016
Primary completion
Dec 16, 2020
Completion
Dec 16, 2020
Last update posted
Mar 15, 2022

2016 – 2020

United States locations

U.S. sites
12
U.S. states
6
U.S. cities
10
Facility City State ZIP Site status
Arizona Liver Health Chandler Arizona 85224
Altman Clinical and Translational Research Clinic La Jolla California 92093
Ruane Clinical Research Group Inc. Los Angeles California 90036
Cedars-Sinai Medical Center Los Angeles California 90048
Stanford Hospital and Clinics (SHC) Stanford California 94305
Florida Research Institute Lakewood Rch Florida 34211
Delta Research Partners, LLC Bastrop Louisiana 71220
Gastro One Germantown Tennessee 38138
Quality Medical Research Nashville Tennessee 37211
Pinnacle Clinical Research, PLLC Live Oak Texas 78233
American Research Corporation at the Texas Liver Institute San Antonio Texas 78215
Pinnacle Clinical Research, PLLC San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02781584, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02781584 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →